Headquartered in Winston-Salem, ProKidney leases an undetermined amount of space at the general-industrial-zoned building at ...

Biotech company ProKidney will no longer be coming to Greensboro, according to the City of Greensboro Chamber of Commerce.

The 73 Business Center on Greenbourne Drive in Greensboro is pictured. ProKidney Corp., a Winston-Salem company focused on ...

It is unclear what will happen to ProKidney's plans for a $458-million, 330-job commercial manufacturing facility in ...

"We remain committed to bringing jobs to North Carolina.” WFMY News 2 followed back up with the company asking for clarify ...

ProKidney's REACT® therapy shows kidney function stabilization. Find out why PROK stock is risky due to cash issues and ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our dialogue ...

Judah Frommer, an analyst from Morgan Stanley, maintained the Hold rating on ProKidney (PROK – Research Report). The associated price target remains the same with $3.00. Judah Frommer has given his ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our ...